Ovarian cancer is one of the most serious and complex cancers affecting women. Despite being the fifth most common cause of cancer-related death among women, it remains relatively under-discussed, often overshadowed by other forms of cancer such as breast and cervical cancer. This lack of awareness can be dangerous, as early detection is crucial for improving the survival rates of those diagnosed with the disease.
In this blog, we will explore the various aspects of the disease, including its causes, symptoms, risk factors, treatment options, and the importance of early detection. We will also delve into the challenges of diagnosing this cancer early and the steps that can be taken to raise awareness and improve outcomes for women around the world.
What is Ovarian Cancer?
Ovarian cancer occurs when abnormal cells in the ovaries—the reproductive glands that produce eggs—begin to grow uncontrollably, forming a tumor. If not detected and treated early, these cancerous cells can spread to other parts of the body, making the disease more difficult to treat.
Types of ovarian cancer:
There are several types of the cancer, the most common being epithelial ovarian cancer, which originates in the thin layer of tissue that covers the outside of the ovaries. Other, less common types include germ cell tumors, which start in the egg-producing cells, and stromal tumors, which begin in the hormone-producing tissue within the ovaries.
Ovarian cancer causes:
The exact cause of this cancer is not fully understood, but several risk factors have been identified that can increase a woman’s likelihood of developing the disease. These include:
- Age: Ovarian cancer is most common in women over the age of 50, with the majority of cases occurring in those aged 60 and above.
- Family History: Women with a family history of ovarian, breast, or colorectal cancer are at an increased risk. This is particularly true if a first-degree relative (mother, sister, or daughter) has been diagnosed with one of these cancers.
- Genetic Mutations: Certain genetic mutations, such as BRCA1 and BRCA2, significantly increase the risk of ovarian cancer. Women with these mutations have a higher lifetime risk of developing ovarian and breast cancers.
- Reproductive History: Women who have never been pregnant or who have had difficulty conceiving are at a higher risk. Conversely, women who have had multiple full-term pregnancies or who have used oral contraceptives for an extended period may have a reduced risk.
- Hormone Replacement Therapy (HRT): Prolonged use of hormone replacement therapy, particularly estrogen-only HRT, has been associated with an increased risk of ovarian cancer.
- Lifestyle Factors: Obesity, a diet high in fats, and a sedentary lifestyle may also contribute to an increased risk of ovarian cancer.
Ovarian Cancer symptoms:
One of the biggest challenges in diagnosing this disease is that its symptoms are often vague and can easily be mistaken for less serious conditions. Common symptoms include:
- Abdominal bloating or swelling
- Pelvic pain or discomfort
- Difficulty eating or feeling full quickly
- Frequent urination or an urgent need to urinate
- Fatigue
- Back pain
- Constipation
- Menstrual changes
These symptoms are often attributed to more benign conditions, such as irritable bowel syndrome or urinary tract infections, leading to delays in diagnosis. However, if these symptoms are persistent and represent a change from normal for the individual, it is important to seek medical advice.
The Importance of Early Detection
Early detection of ovarian cancer is crucial for improving survival rates. When diagnosed at an early stage, before the cancer has spread beyond the ovaries, the five-year survival rate can be as high as 90%. Unfortunately, because the symptoms are often subtle and nonspecific, around 70% of ovarian cancer cases are diagnosed at an advanced stage, when the cancer has already spread to other parts of the body. At this stage, the five-year survival rate drops to around 30%.
There is currently no effective screening test for ovarian cancer, which further complicates early detection. Unlike cervical cancer, which can be detected early through regular Pap smears, ovarian cancer does not have a reliable, routine screening method. However, several diagnostic tools can help in the detection process:
- Pelvic Examination: A pelvic exam can sometimes detect abnormalities in the ovaries, though it is not always effective in detecting early-stage ovarian cancer.
- Transvaginal Ultrasound (TVUS): This imaging test uses sound waves to create pictures of the ovaries and can help identify masses or irregularities.
- CA-125 Blood Test: CA-125 is a protein that is often elevated in women with ovarian cancer. While this test is not definitive (as elevated CA-125 levels can also occur due to other conditions), it can be useful in conjunction with other diagnostic tools.
- CT Scans and MRIs: These imaging tests can provide detailed pictures of the ovaries and surrounding tissues, helping to determine the extent of the disease.
For women at high risk of ovarian cancer (e.g., those with BRCA1 or BRCA2 mutations or a strong family history of the disease), more aggressive monitoring and preventive measures may be recommended, including regular imaging tests, blood tests, and even prophylactic (preventive) surgery to remove the ovaries and fallopian tubes.
Ovarian Cancer treatment
The treatment typically involves a combination of surgery and chemotherapy, and in some cases, targeted therapy or radiation therapy may also be used.
- Surgery: The goal of surgery is to remove as much of the tumor as possible, a procedure known as debulking. Depending on the stage of the cancer, this may involve removing one or both ovaries, the fallopian tubes, the uterus, and any other affected tissues or organs.
- Chemotherapy: Chemotherapy is often used after surgery to kill any remaining cancer cells. In some cases, it may also be used before surgery to shrink the tumor and make it easier to remove. The most common chemotherapy drugs for ovarian cancer are platinum-based (such as carboplatin and cisplatin) and taxanes (such as paclitaxel).
- Targeted Therapy: Targeted therapies, such as PARP inhibitors, are newer treatments that specifically target cancer cells with certain genetic mutations. These therapies can be particularly effective in women with BRCA mutations.
- Radiation Therapy: While not commonly used as a primary treatment for ovarian cancer, radiation therapy may be used in certain cases to target specific areas of the body where cancer has spread.
- Clinical Trials: Participation in clinical trials may be an option for some women, offering access to new and experimental treatments that are not yet widely available.
Living with the disease:
A diagnosis of ovarian cancer can be life-changing, and the treatment process can be physically and emotionally challenging. Support from healthcare professionals, family, friends, and cancer support groups can make a significant difference in coping with the disease.
Regular follow-up care is essential for monitoring the success of treatment and detecting any signs of recurrence. This may involve regular physical exams, blood tests, and imaging studies.
Raising Awareness and Supporting Research
Despite the challenges, there is hope in the fight against ovarian cancer. Advances in research are leading to new and more effective treatments, and awareness campaigns are helping to educate women about the symptoms and risks of the disease.
Organizations like the Ovarian Cancer Research Alliance (OCRA) and the National Ovarian Cancer Coalition (NOCC) play a critical role in funding research, supporting patients, and raising awareness. Events such as Ovarian Cancer Awareness Month (observed in September) and the “Teal Ribbon” campaign help to shine a light on this often-overlooked disease.
Ovarian cancer is a serious and potentially life-threatening disease, but with increased awareness, early detection, and advances in treatment, there is hope for better outcomes. Understanding the risk factors, recognizing the symptoms, and advocating for more research and better screening methods are all crucial steps in the fight against the disease.
By staying informed and supporting initiatives aimed at improving awareness and research, we can help to save lives and improve the quality of life for women affected by this devastating disease.
To get tested for Ovarian Cancer or to consult a Gynecologist, call Sparsh Diagnostic Centre on 9830117733.
#BhaloTheko
Disclaimer:
No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.
Additional Reading:
